Alterity Therapeutics (ATHE) Invested Capital (2009 - 2025)

Alterity Therapeutics' Invested Capital history runs 16 years deep, the most recent figure standing at $7.1 billion for Q4 2025.

• In Q4 2025, Invested Capital rose 105.23% year-over-year to $7.1 billion; the TTM figure through Dec 2025 stood at $7.1 billion (up 105.23% YoY), while the FY2025 annual figure was -$146.4 million, down 1.43% from the prior year.
• Invested Capital was $7.1 billion for Q4 2025 at Alterity Therapeutics, up from -$146.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $7.1 billion in Q4 2025 to a low of -$146.4 million in Q2 2025.
• Historically, Invested Capital has averaged $1.5 billion across 5 years, with a median of $21.7 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Invested Capital surged 549.48% in 2021, then slumped 1231.69% in 2024.
• A 5-year view of Invested Capital shows it stood at $21.5 million in 2021, then soared by 7289.07% to $1.6 billion in 2022, then gained by 14.91% to $1.8 billion in 2023, then jumped by 90.72% to $3.5 billion in 2024, then soared by 105.23% to $7.1 billion in 2025.
• The last three Invested Capital figures came in at $7.1 billion (Q4 2025), -$146.4 million (Q2 2025), and $3.5 billion (Q4 2024), per Business Quant data.